Astellas Pharma Inc. - Free Cash Flow To Equity

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Free-Cash-Flow-To-Equity" stands at 32.03 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025.'
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -412.07 Billion Japanese Yens compared to the value the year prior.
The 1 year change is -412.07 Billion Japanese Yens.
The 3 year change is -105.64 Billion Japanese Yens.
The 5 year change is -390.63 Billion Japanese Yens.
The 10 year change is 180.20 Billion Japanese Yens.

The Serie's long term average value is 112.19 Billion Japanese Yens. It's latest available value, on 06/30/2025, is -80.15 Billion Japanese Yens lower, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 06/30/2015, to it's latest available value, on 06/30/2025, is +180.20 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 09/30/2023, to it's latest available value, on 06/30/2025, is -854.15 Billion.